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ABSTRACT
Bone resorption is dependent on the differentiation of osteoclast (OC)
progenitor cells from the hematopoietic lineage into mature multinucleated OCs
with the ability to resorb mineralized bone. Receptor activator of NF-κB ligand
(RANKL) and macrophage-colony stimulating factor (M-CSF) are vital for
osteoclastogenesis, while osteoprotegerin (OPG), the decoy receptor for RANKL,
inhibits osteoclastogenesis. These factors are produced by osteoblasts (OBs),
which are also the bone-forming cells. Prostaglandin (PG) E2 is a potent
stimulator of resorption. It stimulates osteoclastogenesis by acting on OBs to
induce RANKL and inhibit OPG expression. Less is known about how PGE2 acts
on the hematopoietic lineage to directly regulate osteoclastogenesis. The goal of
this project was to examine the effects of PGE2 on OC formation from purified
bone marrow macrophages (BMMs) in the presence of RANKL and M-CSF.
BMMs were isolated from murine long bones, expanded with M-CSF in
petri dishes, replated in 96-well plates or 48-well plates, and treated with M-CSF
and RANKL (M+R) or M+R plus PGE2. OCs, defined as cells with >3 nuclei
staining for tartrate resistant acid phosphatase (TRAP), were counted in 3 wells
per group on days 4-9 of culture. Counting was done either directly, under the
microscope, or indirectly, with multiple digital images pieced together to create
one seamless image of the entire well, which was then printed out for counting.
Comparison of direct and indirect quantification of OC counts showed a 99.8%
correlation. All experiments were quantified using the indirect method. In 48-well
plates, M+R stimulated OC formation that peaked at d 7 or 8 in 3 independent
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experiments, and PGE2 inhibited OC formation induced by M+R at all time points
and tended to delay the peak OC formation by 24 h. In 96-well plates, M+R
alone had inconsistent results. In these 3 independent experiments the results
showed: either stimulation, no effect leading to stimulation, or a biphasic effect
with early inhibition and later stimulation. The OC formation peaked at d 4, 5, or
d 7. Although effects of PGE2 on formation of OCs from BMMs were variable in
96-well plates, PGE2 consistently inhibited OC formation in 48-well plates. Our
data suggest that direct effects of PGE2 on OC precursors may oppose the
indirect effects of PGE2 to increase OCs via increasing RANKL in OBs.

xi

INTRODUCTION
1. Bone Resorption – Bone resorption is the process by which mineralized
bone is broken down, and the calcium and phosphate in the mineral matrix is
returned to the blood. Resorption is the first step in the bone remodeling cycle,
which replaces “old” bone with “new” bone, and is coupled to bone formation by
many locally produced factors, including some released from the bone matrix by
the resorption process itself. The bone remodeling cycle is important for mineral
homeostasis, for repair of damaged bone, and to allow bone to change its shape
in response to mechanical loading. In particular, bone resorption is necessary for
orthodontic tooth movement.

Osteoclasts (OCs)
OCs are multinucleated cells (MNCs) that resorb mineralized bone. They
develop from the monocyte-macrophage lineage of hematopoietic cells [1]. OCs
express tartrate-resistant acid phosphatase (TRAP) activity and calcitonin
receptors (CTRs). TRAP is an enzyme identified in both the ruffled border of the
OC membrane and in the secretions in the resorptive space [2]. TRAP is highly
expressed by OCs, macrophages, and neurons [3]. The exact function of TRAP
is unknown, but many functions have been attributed to this protein, such as the
generation of reactive oxygen species, iron transport, and regulation of cell
growth and differentiation factor [4]. The CTR is a G protein-coupled receptor
that binds calcitonin. CTR is more specific for OCs than TRAP [4]. Calcitonin is
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involved in the maintenance of calcium homeostasis and can transiently inhibit
OC activity [1].

Osteoclastogenesis
Cell-to-cell contact between cells of the osteoblastic lineage and OC
progenitors is necessary for OC differentiation [5]. Osteoblasts (OBs), which are
derived from precursors in the mesenchymal cell lineage, support OC
development by producing macrophage/monocyte-colony stimulating factor (MCSF) and receptor activator of NF-κB ligand (RANKL). OC differentiation
involves several major stages as illustrated in Figure 1. Hematopoietic stem cells
(HSCs) give rise to colony forming unit-granulocyte/macrophages (CFU-GMs).
M-CSF stimulates the proliferation of CFU-GMs into monocyte/macrophage cells
that lack TRAP and CTR, two crucial OC markers. Mononuclear OC precursors
differentiate into prefusion OCs (cells positive for both TRAP and CTR) in
response to stimulation from M-CSF and RANKL. These factors bind their
respective receptors, c-fms and RANK, expressed on OC precursors to stimulate
OC formation. The prefusion OCs will further develop and differentiate by fusion
to become MNCs (with continuous stimulation of M-CSF and RANKL).
Once MNCs become functional OCs, they present with a ruffled border
and the ability to resorb mineralized bone matrix [6]. The ruffled border
increases the surface area interface for bone resorption [7]. It also creates a
‘Sealing Zone’ around the resorption area, allowing the enzymes to have an
isolated area with a low pH, thus providing the OC with the proper environment
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needed for bone mineral dissolution [8]. RANKL continues to play an important
role in activating OCs by stimulating formation of the ruffled membrane [1].
RANKL may also enhance OC survival [9].

RANKL and Osteoprotegerin (OPG)
RANKL, also called osteoprotegerin ligand (OPGL) [10], is a member of
the TNF superfamily. It is a cell surface molecule expressed not only by OBs but
also by marrow stromal cells and activated T lymphocytes [5]. In vitro, RANKL
and M-CSF have been shown to be sufficient for stimulating osteoclastogenesis
[11]. Both RANKL knockout and RANK knockout mice have osteopetrosis
secondary to complete absence of OCs in bone [12]. OB/stromal cells also
produce osteoprotegerin (OPG), a soluble decoy receptor for RANKL. OPG
inhibits RANKL function by competing with RANK for RANKL [13]. OPG knockout
mice show decreased bone density [14] and defects in tooth eruption and
osteoclastogenesis [14], while mice with over expression of OPG show increased
bone density [15].
For some factors that stimulate resorption, such as parathyroid hormone,
there are no known receptors on cells in the osteoclastic lineage, and their ability
to stimulate resorption is reflected by their ability to stimulate RANKL and inhibit
OPG (or to increase the RANKL:OPG ratio) in OBs. Other factors, such as
prostaglandins, have receptors on OCs as well as on OBs and may, therefore,
have effects on both lineages.
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2. Prostaglandins (PGs) – PGs are 20-carbon polyunsaturated fatty acids
produced by many cell types. Although OCs can produce PGs, the major
source of PGs in bone is thought to be cells of the OB lineage. The production of
PGs, especially PGE2, in OBs is stimulated by many resorption agonists (i.e.,
factors that increase the RANKL/OPG ratio), and PGE2 is itself a potent
stimulator of OC formation [15, 16] Hence, the effects of other resorption
agonists may be modulated by their induction of PGE2.

Regulation of PG Production
Conversion of arachidonic acid (AA), derived from the cellular lipid bilayer,
by cyclooxygenase (COX), also called prostaglandin endoperoxide synthase, is
the committed step in PG synthesis [14] (Figure 2). COX has two isoforms,
COX-1 and COX-2, encoded by separate genes [14]. COX-1 is encoded by a 22
kb gene with 11 exons and COX-2 is encoded by a 8 kb gene with 10 exons [14].
Even though COX-1 and -2 are similar in their enzymatic mechanisms, their
functional roles differ. COX-1 is constitutively expressed in nearly all tissues
(including OBs). COX-1 is thought to produce the PGs responsible for
“housekeeping” functions such as the maintenance of renal blood flow, platelet
aggregation and gastric cytoprotection [17]. In contrast, COX-2 is inducible, and
is responsible for acute PG responses [18]. COX-2 is induced in response to
multiple factors, including cytokines and growth factors (IL-1, TNF-α, TGF-α,
TGF-β), hormones (parathyroid hormone, 1,25(OH)2D3) and mechanical loading
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of bone [19-21]. The induction of COX-2 is generally transient in most cells, with
a return to baseline in 24-48 hours [14].
Non-steroidal anti-inflammatory drugs (NSAIDs) like acetylsalicylic acid
(aspirin) and ibuprofen act to inhibit PG production by preventing binding of AA to
the catalytic site in both COX-1 and COX-2. Newer NSAIDs, such as celecoxib
(Celebrex), are selective for COX-2 [14].

PGE2 and OC Formation
PGE2 can stimulate OC differentiation in various types of in vitro cultures
and bone resorption in bone cultures [14]

Studies have shown that PGE2 can

indirectly increase osteoclastogenesis by increasing RANKL and decreasing
OPG in OBs and can have direct stimulatory effects on the hematopoietic lineage
to increase OC numbers as well [14]. On the other hand, other studies have
reported that PGE2 can inhibit the activity of mature OCs [22]. One study
reported both inhibitory and stimulatory effects of PGE2 on OC formation in
hematopoietic lineage cells [8]. Hence, the effects of PGE2 on OC formation and
activity can be complex, perhaps in part because there are so many different
model systems in which to study OC formation.

3. Models for Studying Osteoclast Formation – A number of different murine
models to study osteoclastogenesis have developed over the years. All of them
require the addition of some “resorption” agonist (some stimulator of RANKL) or
the addition of RANKL itself. Some systems examine effects of indirect actions
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of resorption agonists on OC formation, while others examine direct effects on
the hematopoietic lineage.

Bone Marrow Cultures
Bone marrow contains cells of both the hematopoietic and mesenchymal
lineage. Hence, under appropriate conditions, whole bone marrow can be used
to study either osteoblastic differentiation (called bone marrow stromal cell
cultures) or osteoclastic differentiation (simply called bone marrow cultures).
Although cells of the osteoblastic lineage make M-CSF, RANKL, and OPG, there
is not enough RANKL made under basal culture conditions to stimulate OC
formation. Hence, to differentiate OCs from bone marrow requires the addition of
agonists that can increase RANKL production by cells of the mesenchymal
lineage [23-25]. There cultures are generally used to assess the ability of various
resorption agonists to stimulate the RANKL/OPG ratio and compare with
numbers of OCs formed. Although these cultures do not require
supplementation with either RANKL or M-CSF, addition of RANKL to these
cultures can be examined to determine the maximal number of cells with the
potential to develop into OCs.
In marrow cultures, PGE2 generally stimulates OC differentiation by
increasing RANKL and inhibiting OPG [24]. Since many resorption agonists also
induce COX-2 in these cultures, some of the ability of these agonists to induce
OC formation is dependent on their induction of PGs. This has been shown by
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treating these cultures with NSAIDs to inhibit PG production or by using cells
from COX-2 knockout mice [24].

Spleen Cultures
Spleen cultures contain precursor OCs and no OB precursors. Therefore,
these cultures can be used to examine direct effects of agonists on OC
precursors. Since there are no osteoblastic cells present, the cultures require
supplementation with M-CSF and soluble RANKL. If one wants to study the
contribution of mesenchymal cells from one type of transgenic mouse and
hematopoietic cells from another type, then co-cultures combining OBs from one
type of transgenic mouse with spleen cells from another type can be used.
It has been shown that PGE2 can increase the combined effects of
RANKL and M-CSF to stimulate OC formation in some spleen cultures [25, 26].
For example, our lab found that there was a 50% reduction in OCs formed in the
presence of RANKL and M-CSF when the spleen cells came from COX knockout
mice [24]. This was explained as being due to increased expression of
granulocyte monocyte-colony stimulating factor (GM-CSF), an inhibitor of OC
formation, in COX-2 knockout spleen cultures [26]. However, that study
measured OC formation only at one time point. In another study where OC
formation was examined over multiple time points, we found that PGE2, in the
presence of RANKL and M-CSF, had biphasic effects on OC formation [26].
PGE2 decreased the number of OCs at 5-6 days of culture but increased the
number of OCs at 8-9 days compared with cultures treated with RANKL and M-
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CSF alone [24]. The increase in OC number at the later time point may have
been due to the observation that PGE2 decreased OC apoptosis at day 7. It was
concluded that PGE2 has an initial inhibitory effect on OC formation in spleen cell
cultures and a later stimulatory effect mediated by the EP2 receptor [24]. Spleen
cultures also contain T cells, and it was speculated that the T cells were
responsible for the initial inhibitory effects of PGE2 on osteoclastogenesis in this
system. Hence, both stimulatory and inhibitory effects of PGE2 on OC formation
have been seen in spleen cultures.

Peripheral Blood Mononuclear Cells (PBMCs)
PBMCs are a subset of white blood cells having a round nucleus, such as
a lymphocyte or a monocyte, that can give rise to OCs in culture when treated
with RANKL and M-CSF. The advantage of PBMCs above other cells is that
blood is a readily accessible cellular material, and PBMCs can be isolated from
whole blood relatively easily. Various studies have shown that PBMCs can
display gene expression patterns characteristic for certain diseases, such as
acute myeloid leukemia, atherosclerosis, and autoimmune diseases [27].
The effects of PGE2 on human OC formation were examined in cultures
of CD14+ cells prepared from human PBMCs [28]. PGE2 in the presence of
RANKL and M-CSF inhibited OC formation in these cultures. The conditioned
medium of CD14+ cells pretreated with PGE2 inhibited RANKL-induced OC
formation not only in human CD14+ cell cultures but also in mouse macrophage

8

cultures. The authors concluded that PGE2 inhibits human OC formation in
PBMC cultures through the production of an as yet unknown inhibitory factor.

RAW 264.7 Cultures
RAW264.7 cells are the only known clonal cell line that can give rise to
OCs in vitro. The RAW 264.7 cell line is a functional murine macrophage cell line
transformed by the Abelson Leukemia Virus. Hence, they may not reflect
‘normal’ OC development. These cells produce cytokines in response to
lipopolysaccharide (LPS) and can make OCs in response to RANKL [29]. Since
RAW 264.7 cells produce M-CSF, it is not necessary to add M-CSF to cultures.
Several studies have suggested that PGE2 can enhance
osteoclastogenesis in the RAW 264.7 cell line [29]. On the other hand, a study in
our lab examining OC formation in RAW 264.7 cells treated with tumor necrosis
factor (TNF-α) found that inhibition of PGE2 production in these cultures
stimulated the formation of OC [30].

Bone Marrow Macrophage Cultures
Bone marrow macrophages (BMMs) are primary macrophages/monocytes
isolated from bone marrow that can be differentiated into OCs [31-38]. BMMs
are expanded in M-CSF and then treated with RANKL to stimulate OC formation.
Compared to many other primary cells, BMMs are relatively homogenous, have a
proliferative capacity, are transfectable, and have a lifespan longer than a week.
In fact, BMMs can be grown up to three weeks without noticeable cell death or
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altered morphology [39]. There is little known regarding the effects of PGE2 on
BMM cell cultures.

4. OC Quantification
Quantitative assessment of OC numbers are essential to allow statistical
comparisons between treatment groups, and to facilitate reference databases for
the study of metabolic bone diseases associated with increased bone resorption.
Some methods have included scoring systems to evaluate TRAP staining
intensity [40], and grid systems to evaluate TRAP distribution [41], however,
TRAP levels are subjectively graded (e.g., 1 to 4) rather than actually quantifying
cell numbers, stain density, or area percentages. Although many studies have
provided valuable information regarding TRAP distribution and histomorphometry
of resorbing cells, no study has offered a precise method for quantifying TRAP
positive cells or OCs.
With the development of faster computers and better cameras, more
sophisticated forms of image analysis have been introduced allowing images
from the microscope to be captured and transmitted to a computer equipped with
image analysis tools [41]. In our study, we will use digital imaging and
computers, to standardize the size and location of the region of interest, quantify
the positive OC staining area, document the reproducibility of the measurements,
create a permanent record of the OC wells of interest, and demonstrate a direct
correlation with the current "gold standard" of OC quantification performed
directly under a microscope.
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5. Bone Resorption, PGs and Orthodontic Tooth Movement
Tooth movement is a coordinated array of events involving bone
resorption and formation. The efficiency of bone resorption is the rate-limiting
factor in tooth movement [41-44]. Bone is removed in front of the moving tooth
by two mechanisms: frontal resorption at the periodontal ligament (PDL) interface
and initial remodeling events (resorption cavities) in the cortical plate [45, 46].
Orthodontic force initiates a cascade of cellular proliferation and differentiation
events in the PDL [47-51]. A variety of neurological, immune, and endocrine
system responses, as well as local cytokines and intracellular messages, have
been implicated in the osseous adaptive reaction as the root of the tooth is
displaced [52]. These localized agents are likely mediators of the temporary
discomfort noted during the initiation of orthodontic tooth movement. The role of
local cytokines in the sustained bone modeling and remodeling events of tooth
movement is largely unknown. However, PGs are thought to be important factors
in the control of mechanically mediated bone adaptation [53].
Among other factors, the removal of osseous tissue during progressive
tooth movement is directly related to the resorption rate and to OC recruitment.
The OC resorption rate is largely controlled by metabolic factors [54]. There is
currently no direct evidence to suggest that OCs are produced in the PDL. PreOCs can be derived from the bone marrow, enter the circulation and
subsequently be delivered to the PDL and adjacent bone [14]. It has been
shown that PDL cells also require cell-to-cell contact to stimulate
osteoclastogenesis [55]. During the application of orthodontic forces, RANKL

11

has been seen in OBs, osteocytes, and fibroblasts [55]. Also, the RANKL/OPG
ratio has been implicated in root resorption associated with heavy orthodontic
forces applied in rats [56].
PGs are potent stimulators of bone resorption, and have been shown to
be produced when teeth are mechanically loaded and to enhance tooth
movement [14, 17]. For example Yamasaki et al [55] showed that orthodontic
mechanical stress induced secretion of PGs in the periodontal tissues of rats
stimulated OC bone resorption. When PGE1 or PGE2 were injected in the
gingiva near the upper first molar in rats, OCs and alveolar bone resorption were
observed [23, 57, 58]. On the other hand, the administration of indomethacin, an
inhibitor of PG production, suppressed the appearance of OCs and bone
resorption. Indomethacin also decreased the extent of resorption surfaces in
response to orthodontic loading in miniature pigs [59]. Orthodontic forces have
also been shown to increase cytokine production, such as TNF-α and IL-1, which
can induce COX-2 expression and PG production in OBs and in cultured bone
marrow cells [28]. Although these cytokines are themselves potent inducers of
bone resorption, some of their effects on resorption may be mediated via their
induction of COX-2 and PGs [26].
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RATIONALE
In order for tooth movement to occur, bone resorption has to take place on
the compression side followed by bone deposition on the tension side. Thus,
OCs play a crucial role in tooth movement. Although PGs have been shown to
enhance orthodontic tooth movement, it is unclear if this enhancement involves
not only PG stimulation of the RANKL/OPG ratio in OC supporting cells (PDL
cells and/or OBs) but also stimulatory effects on cells of the osteoclast lineage.
As discussed above, the effect of PGE2 to increase RANKL/OPG is well
documented, but PGE2 has been shown to have both stimulatory and inhibitory
effects on OC formation in different models used to study OC formation. One
explanation for the differences seen in studies of the direct effects of PGE2 on
OC precursors may be the time points at which OC formation was quantified. In
spleen cell cultures studied over an extensive time course, PGE2 had biphasic
effects, an initial inhibitory effect on OC formation with a later stimulatory effect
[60]. Preliminary data from our lab, studying OC formation in cultured BMMs also
suggest that PGE2 may have inhibitory effects. One of the difficulties with
studying BMMs is that very large numbers of OCs are formed, making counting
under the microscope tedious, time-consuming, and operator dependent. The
goals of this project were to develop a digital method of recording OC counts and
to use this method to examine the effects of PGE2 on OC formation from purified
BMMs in the presence of RANKL and M-CSF over an extended time course.
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HYPOTHESIS
1. Digital imaging will strongly correlate with the conventional method of OC
quantification.

2. PGE2 will inhibit or delay OC formation in BMM cultures.

OBJECTIVES
The overall objective of this research was to clarify the effects of PGE2 on
OC formation in BMM cultures. The specific objectives were:

1. To create a method that permitted convenient quantification of large
numbers of OCs.

2. To examine the effects of exogenous PGE2 on the differentiation of OC
precursors into OCs in BMM cultures.

a) Examine the effects of a dose response of PGE2 on BMM cells.

b) Examine the time course for effects of PGE2 on BMM cells.
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MATERIALS AND METHODS
1. Materials
RANKL and M-CSF were obtained from R&D Biosystems (Minneapolis,
MN). PGE2 was obtained from Cayman Chemical Company (Ann Arbor, MI).
Minimal Essential Medium Alpha (α-MEM), fetal calf serum (FCS), and
trypsin/EDTA were purchased from Invitrogen (Carlsbad, CA). Leukocyte Acid
Phosphatase Kit (TRAP stain) was purchased from Sigma (St. Louis, MO).

2. Bone Marrow Macrophage (BMM) Cultures
Isolation of BMMs
All animals used in this study were treated in accordance with protocols
approved by the Animal Care and Use Committee of the University of
Connecticut Heath Center. Long bones (femur and tibia) of 8 week old CD1 mice
(males and females) were dissected free of adherent tissue and placed into
sterile dishes on ice. Bone marrow was flushed with alpha MEM (without serum)
under the hood using syringes with 25 gauge needle (1ml per bone). The bone
marrow cells were then resuspended in alpha MEM + 10% FCS + 100 ng/ml MCSF and plated at 5X106 cells per/well in 100 mm petri dish (Fisher brand 08757-12). Adherent cells, the bone marrow macrophages (BMMs), were lifted
after 3 days with trypsin/EDTA, centrifuged and resuspended in alpha MEM
+10% FCS + 30 ng/ml MCSF and 100 ng/ml RANKL and plated in either 48 or 96
well dishes for osteoclastogenesis experiments.
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Osteoclastogenesis
5,000 cells/well were plated in 96 well plates and 15,000 cells/well in 48
well plates. The media, which consisted of alpha MEM +10% FCS + 30 ng/ml MCSF and 60 or 100 ng/ml RANKL, was changed every 2-3 days. Cells were
cultured for a time course of 4-9 days, depending on the experiment. The cells
were also subjected to different concentrations of PGE2, either 10-6 M or 10-8 M.
Please see individual experiments under ‘Results’ section for exact time course
and PGE2 concentrations for each individual experiment.

Expansion
Left over BMMs were expanded at 5X106 cells per/well in 100 mm petri
dish in alpha MEM +10% FCS + 100 ng/ml M-CSF for future osteoclastogenesis
experiments.

3. Tartrate Resistant Acid Phosphatase (TRAP) Staining
Cells were fixed at the end of culture with 2.5% glutaraldehyde. A
Leukocyte Acid Phosphatase Kit was used to stain for TRAP following the
manufacturer’s instructions. The TRAP positive multinucleated cells (MNCs),
with 3 or more nuclei, were either directly counted under the microscope at 20X
total magnification or indirectly counted via digital imagery at 20X total
magnification.
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4. OC Quantification
Direct OC Quantification
The TRAP stained plates were placed under a high power light
microscope (Olympus IX70, Melville, New York) and viewed at 20X total
magnification. Due to the high power magnification needed to view the OCs
nuclei, it was not possible to view the entire well under one field of view. In order
to view the entire well, the built in eyepiece grid was used to ensure proper
tracking of the well during quantification. Each TRAP positive cell with 3 or more
nuclei was counted using a handheld click counter. An OC tally of each well from
each plate was recorded and graphed.

Indirect OC Quantification
The TRAP positive plates were placed under a high power light
microscope (Nikon Eclipse TE2000-U, Tokyo, Japan) and viewed at 20X total
magnification. The microscope was connected to a digital camera (Spot RT
Slider, Diagnostic Instruments, Sterling Heights, MI) and the images were
captured using Windows Spot Advanced software version 4.1 (Diagnostic
Instruments, Sterling Heights, MI). Due to the high power magnification needed
to view the OCs nuclei, it was not possible to view the entire well under one field
of view. Multiple images were merged into one complete and seamless image
using Adobe Photoshop CS2 (Adobe Systems Incorporated, San Jose, CA),
printed using a photo quality color printer, Hewlett-Packard Color Laser Jet
4700dn (Hewlett-Packard, Palo Alto, CA), and the OCs were quantified.
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5. Design Overview
Bone Marrow Macrophage Isolation

Bone Marrow Macrophage Expansion

Continue Bone Marrow Macrophage
Expansion (up to 4 passages)

Osteoclastogenesis

Fix and Stain Osteoclasts

Osteoclast Quantification

6. Statistical Analysis
All values are depicted as the mean ± standard error of the mean (SEM).
Statistical analysis was performed using GraphPad Prism® for Microsoft
Windows®, version 4.0 (GraphPad Software, La Jolla, CA). To compare multiple
treatment groups, differences were examined by two-way analysis of variance
(ANOVA) followed by the Bonferroni test.
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RESULTS
1. Comparison of Direct and Indirect OC Quantification
Our first goal of this project was to create a method that will permit a
reliable and convenient quantification of large numbers of OCs. The wells of 48
well plates were divided into sextants, and six different images of the same well
were captured and later pieced back together to create one seamless image
(Figure 3). The wells of 96 well plates were divided in half, and two different
images of the same well were captured and later pieced back together to create
one seamless image (Figure 4). The images were then printed and the OCs
counted.
Only ‘normal’ and ‘healthy’ appearing multinucleated TRAP positive cells
were counted. ‘Ghost’ cells, cells with degraded membranes, or cells with less
than 3 nuclei were not quantified (Figure 5).
Following the protocol listed above, a correlation between direct (directly
under the light microscope) OC quantification and indirect (using the digital
photography method) OC quantification was compared (Figure 6, Table 1) and
graphed (Figure 7). The results of the correlation experiments showed a 99.81%
correlation between the direct and indirect quantification of OC counts (Figure 7).
Since the indirect quantification method has many advantages over the direct
method, all the remainder of our experiments were quantified using the indirect
method.
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2. Effects of PGE2 on OC Formation
The second aim was to examine the direct effects of exogenous PGE2 on the
differentiation of OCs in BMM cultures. For these experiments, we added PGE2
to BMM cells from CD1 mice, in the presence of M-CSF and RANKL, and
observed OC formation. We did a total of six experiments. Since we found that
the size of the wells in the dishes used affected the results, we have divided the
experimental results according to the size of the wells.

Effects of PGE2 using 48 well plates
Experiment 1 was done in 48 well dishes (Table 2, Fig. 8). Cultures were
treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without PGE2
(10-6 M). OCs were counted on days 5, 6, 7, and 8. OC counts peaked at day 7
for both control (RANKL and M-CSF) and treatment (PGE2) groups. PGE2
decreased the peak OC count by 84%.
Experiment 2 was also done in 48 well dishes (Table 3, Fig. 9). Cultures
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without
PGE2 (10-6 M or 10-8 M). OCs were counted on days 6, 7, 8 and 9. OC counts
for the control group peaked at day 7. OC number in the PGE2 10-8 M group
peaked at day 8. OC number in the PGE2 10-6 M group showed a slow steady
increase without a true peak. For both treatments, PGE2 had an inhibitory effect
on OC formation, with PGE2 10-6 M being more inhibitory than PGE2 10-8 M.
PGE2 10-8 M decreased the peak OC count by 36% and PGE2 10-6 M decreased
the peak OC count by 93%.
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Experiment 3 was also done in 48 well dishes (Table 4, Fig. 10). Cultures
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without
PGE2 (10-6 M or 10-8 M). OCs were counted on days 5, 6, 7, 8 and 9. OC counts
for the control group and the PGE2 10-8 M group both peaked on day 7, while OC
numbers for the PGE2 x 10-6 M group peaked at day 8. PGE2 had an inhibitory
effect on OC formation, with PGE2 X 10-6 M being more inhibitory than PGE2 10-8
M. Peak OC count was decreased by 14% in the PGE2 10-8 M group and by
41% in the PGE2 10-6 M group.

Effects of PGE2 using 96 well plates
Experiment 4 was done in 96 well dishes (Table 5, Fig. 11). Cultures were
treated with M-CSF (30 ng/ml) and RANKL (60 ng/ml), with and without PGE2
(10-6 M or 10-8 M). This was the only experiment where 100 ng/ml of RANKL was
not used. OCs were counted on days 6, 7, 8 and 9. OC counts for all 3 groups
peaked at day 7. Both PGE2 groups had a stimulatory effect on OC formation,
with PGE2 10-8 M being more stimulatory than the PGE2 10-6 M group. PGE2 10-8
M increased the peak OC count by 89% and PGE2 10-6 M increased the peak OC
count by 36.7%.
Experiment 5 was also done in 96 well dishes (Table 6, Fig. 12). Cultures
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without
PGE2 (10-6 M). OCs were counted on days 4, 5, 6, and 7. There was no
appreciable difference in OC counts at days 4 and 5, for the control group or the
PGE210-6 M group. At later time points, however, PGE2 had a stimulatory effect
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(days 6, and 7.) Thus, our conclusion from this experiment was that PGE2 10-6 M
had a no effect early on leading to a later stimulation of OCs.
Experiment 6 was also done in 96 well dishes (Table 7, Fig. 13). Cultures
were treated with M-CSF (30 ng/ml) and RANKL (100 ng/ml), with and without
PGE2 (10-6 M). OCs were counted on days 4, 5, 6, and 7. OC counts peaked at
day 5 for both the control group and the PGE2 10-6 M group. In this experiment,
PGE2 10-6 M had an initial inhibitory effect, and a later stimulatory effect. Thus,
our conclusion from this experiment was that PGE2 10-6 M had a biphasic effect.
Please see Table 8 for the overall experimental results for all 6
experiments.
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DISCUSSION
We developed an “indirect” method for quantifying OC numbers. Multiple
high power fields were photographed and merged together to give prints of whole
wells of cells. This method of counting OCs showed a 99.8% correlation with the
direct counting of OC under a microscope. It also gave us a hard copy of the
data that could be filed for later review by other investigators.
The experiments to study effects of PGE2 on OC formation were
unexpectedly complicated by finding that results varied with size of the well used
to culture OCs. Three independent experiments using 48 well dishes showed
that PGE2 had an inhibitory effect on osteoclastogenesis. The higher dose of
PGE2 (10-6 M) was more inhibitory than the lower dose of PGE2 (10-8 M). In
these experiments, the peak OC number consistently occurred on day 7-8 in both
control (RANKL + M-CSF) cultures and in PGE2-treated cultures.
In contrast, the 96-well experiments had inconsistent results. In these 3
independent experiments the results showed: either stimulation, no effect leading
to stimulation, or a biphasic effect with early inhibition and later stimulation. The
OC formation peaked at d 4, 5, or d 7. Although effects of PGE2 on the formation
of OCs from BMMs were variable in 96-well plates, PGE2 consistently inhibited
OC formation in 48-well plates. In addition, the higher dose of PGE2 (10-6 M) was
less stimulatory than the lower dose of PGE2 (10-8 M).
We do not think that this variability is the result of plating density. The
48 and 96 well plates have surface growth areas of 0.95 cm2 and 0.32 cm2
respectively. The 48 well plates were plated with 15,000 cells per well, while the
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96 well plates were plated with 5,000 cells per well. Hence, our plating densities
2

were similar at 15,600-15,800 cells per cm . However, there was a difference in
the ratio of circumference to growth area in the dishes. The 48 well plate has a
3.45 cm circumference or 3.6 cm per cm2 of growth area, while the 96 well plate
has a 2 cm circumference or 6.2 cm per cm2 of growth area. There may be
greater “edge effects” in the smaller well, such that more cells are sensing the
well wall instead of other cells. Interaction with the well wall might cause cells to
react differently than if they were interacting with other cells
Others have also observed variability in these types of models to study
OC formation. One group of researchers had a similar situation to ours, so they
performed 46 similar experiments for a time course of 26 days [60].
Unexpectedly, they found that OC numbers changed in a manner much more
complex than current knowledge could predict [60]. They observed synchronized
waves of OC formation and death and OC oscillations [60]. In other words, when
they cultured cells for a longer time period, they observed a second wave of OC
formation after the first wave disappeared (i.e., all initial OCs had died). They
also observed that the second wave had a greater amplitude than the first [60].
In several experiments, they even observed a third wave of OC formation, larger
than the previous two waves. They examined different plating densities but did
not see an affect on the rate of OC formation. However, they found that
experiments performed with low concentration of RANKL (10 ng/ml) did not
exhibit this oscillating OC formation pattern, and the experiment groups with a
high concentration of RANKL (100 ng/ml) developed OCs with oscillatory
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behavior more frequently [60]. They concluded that RANKL concentration, not
plating density, significantly affects the probability of the experiment to exhibit
oscillations in osteoclast number [60].
Five of our 6 experiments were done using a ‘high’ concentration of
RANKL (100ng/ml). Experiment 4 was also done using relatively ‘high’
concentration of RANKL (60ng/ml). Perhaps our experiments were exhibiting the
‘oscillations’ described above but we did not follow them long enough to see
these oscillations. It is possible that the effects of PGE2 were simply to delay,
relative to the control cultures, the wave of OC formation, causing the PGE2
treated wave to be offset from the control treated wave (Figure 14). If this were
the case, whether PGE2 caused stimulation, inhibition, or a biphasic event would
simply depend on where the measurement was made relative to the positions of
the control and PGE2 treated waves. As can be seen from the hypothetical
situation illustrated in Figure 14, the conclusion taken from the counts at days 4,
5, and 6 would be that PGE2 has an inhibitory effect, while at day 7 there was no
significant difference, and at days 8, 9, and 10 PGE2 was stimulatory. Whether
or not this delay in OC formation will be important in vivo is not known. It is
unrealistic to have such micro-controlled environments for days to weeks at a
time, when in vivo, these environments may last for only minutes to hours. .
Clearly these data suggest that we should examine the effects of PGE2 on
OC formation using lower doses of RANKL, where oscillations are not expected
to occur. Further examination is needed to determine whether the size of the
culture well produces a different outcome when plated at the same density. The
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effects of looking at cell growth rate and the age of the mice from which the
BMMs were isolated may also be important factors in osteoclastogenesis that
require further examination. We would also like to develop mice that have COX2 deleted specifically from OC precursors. We could then look at the resorption
response in vivo to agents that stimulate resorption.
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SIGNIFICANCE
Overall, our study provides new information about the quantification of
OCs and the process of osteoclastogenesis by taking into account the dose
response and time course associated with BMM cultures using PGE2. Our study
also highlights the difficulties in creating such models in a biologically accurate
manner. This study gives us a better understanding of the role of
osteoclastogenesis and bone remodeling and its mechanism of action via PGs.
It gives orthodontists greater insight into the mechanisms involved in stimulation
and inhibition of tooth movement. This in turn could improve the quality and
efficiency of treatment.
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TABLES

Solution
M
M+R
M + PGE2 -6 M
M + R + PGE2 -6 M
M + PGE2 -8 M
M + R + PGE2 -8 M

Direct Microscope Count
Day Day Day Day
Day
6a
6b
7a
7b
8a
0
0
0
0
0
665 543 754 829
531
0
0
0
0
0
12
21
50
47
44
0
0
0
0
0
213 203 361 318
565

Day
8b
0
648
0
57
0
520

Day
9a
0
338
0
51
0
236

Solution
M
M+R
M + PGE2 -6 M
M + R + PGE2 -6 M
M + PGE2 -8 M
M + R + PGE2 -8 M

Indirect Digital Photo Count
Day Day Day Day Day
6a
6b
7a
7b
8a
0
0
0
0
0
769 638 866 942 609
0
0
0
0
0
11
19
48
44
46
0
0
0
0
0
247 184 419 368 593

Day
8b
0
754
0
54
0
565

Day
9a
0
385
0
53
0
266

Day
9b
0
237
0
62
0
238

Day
9b
0
278
0
68
0
266

Table 1: Osteoclast (OC) counts: comparison of direct and indirect quantification
methods.

Indirect Digital Photo Count for Experiment #1
Day Day
Day
Day
Day
Day
Solution
5a
5b
6a
6b
7a
7b
M
0
0
0
0
0
0
M+R
207
227
462
536
621
697
M + PGE2 -6 M
0
0
0
0
0
0
-6
M + R + PGE2 M 35
57
45
68
107
104
Table 2: OC quantification for Experiment 1.
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Day
8a
0
396
0
64

Day
8b
0
403
0
59

Indirect Digital Photo Count for Experiment #2
Day Day
Day
Day
Day
Day
Solution
6a
6b
7a
7b
8a
8b
M
0
0
0
0
0
0
M+R
769 638
866
942
609
754
-6
M + PGE2 M
0
0
0
0
0
0
M + R + PGE2 -6 M
11
19
48
44
46
54
M + PGE2 -8 M
0
0
0
0
0
0
M + R + PGE2 -8 M
247 184
419
368
593
565

Day
9a
0
385
0
53
0
266

Day
9b
0
278
0
68
0
266

Table 3: OC quantification for Experiment 2.

Indirect Digital Photo Count for Experiment #3
Solution
Day 5a Day 5b Day 5c Day 6a Day 6b
M+R
50
32
44
146
126
-6
M+R+PGE2 M
5
3
3
15
30
-8
M+R+PGE2 M
27
22
23
96
103

Day 6c
147
29
83

Solution
M+R
M+R+PGE2 -6 M
M+R+PGE2 -8 M

Day 7a
272
77
263

Day 7b
303
75
247

Day 7c
316
74
256

Day 8c
223
191
222

Solution
M+R
M+R+PGE2 -6 M
M+R+PGE2 -8 M

Day 9a
101
34
86

Day 9b
106
63
91

Day 9c
91
49
103

Table 4: OC quantification for Experiment 3.
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Day 8a
249
152
224

Day 8b
287
183
241

Indirect Digital Photo Count for Experiment #4
Day
Day Day Day
Day
Day
Solution
6a
6b
6c
6d
7a
7b
M
0
0
0
0
0
0
M+R
61
54
35
35
233
159
M+PGE2 -6 M
0
0
0
0
0
0
-6
M+R+PGE2 M
88
61
72
68
239
274
M+PGE2 -8 M
0
0
0
0
0
0
-8
M+R+PGE2 M
76
97
83
126
442
323

Day Day
7c
7d
0
0
191 187
0
0
263 277
0
0
339 351

Indirect Digital Photo Count for Experiment #4
Day
Day Day Day
Day
Day
Solution
8a
8b
8c
8d
9a
9b
M
0
0
0
0
0
0
M+R
47
26
27
26
39
17
M+PGE2 -6 M
0
0
0
0
0
0
M+R+PGE2 -6 M
176
165
232
210
111
97
M+PGE2 -8 M
0
0
0
0
0
0
M+R+PGE2 -8 M
62
57
35
35
33
39

Day Day
9c
9d
0
0
19
35
0
0
112 88
0
0
37
32

Table 5: OC quantification for Experiment 4.

Indirect Digital Photo Count for Experiment #5
Day
Day
Day
Day
Day
Solution
4a
4b
4c
5a
5b
M+R
117
137
148
78
136
M + R + PGE2 -6 M
162
102
105
137
128

Day
5c
133
117

Indirect Digital Photo Count for Experiment #5
Day
Day
Day
Day
Day
Solution
6a
6b
6c
7a
7b
M+R
13
21
19
21
22
-6
M + R + PGE2 M
45
106
120
41
45

Day
7c
19
57

Table 6: OC quantification for Experiment 5.

30

Indirect Digital Photo Count for Experiment #6
Day
Day
Day
Day
Day
Solution
4a
4b
4c
5a
5b
M+R
83
59
73
101
90
-6
M + R + PGE2 M
16
24
16
66
33

Day
5c
71
54

Indirect Digital Photo Count for Experiment #6
Day
Day
Day
Day
Day
Solution
6a
6b
6c
7a
7b
M+R
17
17
4
12
8
M + R + PGE2 -6 M
32
59
48
17
35

Day
7c
6
31

Table 7: OC quantification for Experiment 6.

Overall Experimental Results
Experiment #

Well Size

PGE2 Effect on OC
Formation

1

48

Inhibition

2

48

Inhibition

3

48

Inhibition

4

96

Stimulation

5

96

No Effect  S

6

96

Biphasic (I  S)

Table 8: Overall Experimental Results.
Inhibition (I) – The Total OC counts of the experiment group (group with PGE2)
was less than the control group (group without PGE2).
Stimulation (S) – The total OC counts of the experiment group (group with PGE2)
was more than the control group (group without PGE2).
No Effect  S – The experiment group and control groups showed no
appreciable difference between OC counts at early time points. At later time
points, the experiment group showed stimulation.
Biphasic (I  S) – When the experiment group showed inhibition at early time
points and stimulation at later time points.
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FIGURES

HEMATOPOIETIC
STEM CELL

CELLS OF MONOCYTEMACROPHAGE LINEAGE
M-CSF
CTR (-), TRAP (-)
RANKL
M-CSF

CFU-GM

PREFUSION
OSTEOCLASTS
CTR (+), TRAP (+)

Differentiation

Proliferation

ACTIVATED
OSTEOCLAST

Survival
and
fusion

MULTINUCLEATED
OSTEOCLAST

M-CSF
RANKL

RANKL
Activation and
Survival
CTR (+), TRAP (+),
Multinucleation (+),
Ruffled border (-)

CTR (+), TRAP (+),
Multinucleation (+),
Ruffled border (+)

Figure 1: Osteoclast (OC) differentiation pathway.

Membrane Phospholipids
Phospholipases
Arachidonic Acid
Cyclooxygenase
PGG2

Cyclooxygenase

Peroxidase
PGH2

Specific Synthases

PGE2

PGD2

PGF2

PGI2

TxA2

Figure 2: Arachidonic acid (AA) metabolic pathway leading to the production of
prostaglandins (PG).
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Individual photos

Photo Merge

a.

b.

Figure 3: 48 well photo merge. a) The wells of 48 well plates were divided into
sextants, and six different images of the same well were captured. b)
Reconstruction of 48 well dish creating one seamless image.

Photo Merge

Individual photos

a.

b.

Figure 4: 96 well photo merge. a) The wells of 96 well plates were divided in
half and two different images of the same well were captured. b) Reconstruction
of 96 well dish creating one seamless image.
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a

b

c

Figure 5: Expanded view of an experimental well. a) “Normal” healthy looking
OC with multiple nuclei. b) “Ghost” OC showing complete degradation of the cell
membrane. c) TRAP positive OC showing partial cell membrane degradation and
cell fragments. Note: only “Normal” appearing OCs were quantified. ‘Ghost’
cells, cells with degraded membranes, or cells with less than 3 nuclei were not
quantified. Cells b and c would not be quantified.
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Day 7

Day 6

Day 8

Day 9

M
M+R
M + PGE2 x 10-6 M
M + R + PGE2x 10 -6 M
M + PGE2 x 10 -8 M
M + R + PGE2 x 10 -8 M

Figure 6: Tartrate resistant acid phosphatase (TRAP) stained bone marrow
monocyte/macrophage (BMM) cells from CD-1 mice. BMM Cells from CD1 mice
were cultured with macrophage-colony stimulating factor (M-CSF or M), receptor
activator of NF-κB ligand (RANKL or R), and different PGE 2 concentrations over
a 4 day time course . Cultures were TRAP stained and TRAP positive
multinucleated cells (MNC) were directly counted under a light microscope and
indirectly counted using the digital photography method. The results were
charted and graphed.
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Correlation
Microscope vs. Digital Photo Count
1000

900

Digital Photo Counts

800

700

600

500

Well Counts
Slope = 1

400

300

200

100

0
0

100

200

300

400

500

600

700

800

900

1000

Direct Microscope Counts
R2 = 0.9981, Y=mX + b, Y=1.139X – 2.137, P <0.0001
Figure 7: Correlation of OC counts using the direct and indirect methods. The
black squares symbolize the actual OC counts from the direct and indirect
quantification methods from each well. The red line symbolizes a 100%
correlation between the direct and indirect quantification method, which would
yield a slope of 1. A 99.81% correlation was found between the direct and
indirect method.
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Osteoclast Count

Experiment 1
700

M+R

600

M+R+PGE2 x10-6

500
400
300
200
a

100
0

4

b

a

5

6

a

7

8

9

Day
Figure 8: Experiment 1: Effect of PGE2 on OC formation in BMMs cultured in 48
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the
presence or absence of PGE2 (10-6 M) for 5-8 days. Cultures were TRAP
stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. a Significant effect of
PGE2, p<0.001; b p<0.01
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Osteoclast Count

Experiment 2
1000
900
800
700
600
500
400
300
200
100
0

M+R
M+R+PGE2 x10-6
M+R+PGE2 x10-8
a
a

a, e

5

6

a, d

a, d

a, e

7

8

9

10

Day
Figure 9: Experiment 2: Effect of PGE2 on OC formation in BMMs cultured in 48
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the
presence or absence of PGE2 (10-6 M or 10-8 M) for 6-9 days. Cultures were
TRAP stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. a Significant effect of
PGE2 p<.001. d Significantly different from PGE2 x 10-8, p<.001; e p<.01.
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Experiment 3
Osteoclast Count

400
300

M+R
M+R+ PGE 2 x10 -6
M+R+ PGE 2 x10 -8

b
a, d

200
b
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b
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0
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7
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Day
Figure 10: Experiment 3: Effect of PGE2 on OC formation in BMMs cultured in 48
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the
presence or absence of PGE2 (10-6 M or 10-8 M) for 5-9 days. Cultures were
TRAP stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. a Significant effect of
PGE2, p<.001, b p<.01. d Significantly different from PGE2 x 10-8, p<.001.
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Experiment 4
Osteoclast Count
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M+R
a
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a, d
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a, d
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Day
Figure 11: Experiment 4: Effect of PGE2 on OC formation in BMMs cultured in 96
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 60 ng/ml), and in the
presence or absence of PGE2 (10-6 M or 10-8 M) for 6-9 days. Cultures were
TRAP stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. a Significant effect of
PGE2, p<.001; c p<.05. d Significantly different from PGE2 x 10-8, p<.001.
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Osteoclast Count

Experiment 5
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Figure 12: Experiment 5: Effect of PGE2 on OC formation in BMMs cultured in 96
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the
presence or absence of PGE2 (10-6 M) for 4-7 days. Cultures were TRAP
stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. b Significant effect of
PGE2,p<.01.
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Experiment 6
M+R
M+R+PGE 2 x10 -6
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Figure 13: Experiment 6: Effect of PGE2 on OC formation in BMMs cultured in 96
well dishes treated with M-CSF (M, 30 ng/ml), RANKL (R, 100 ng/ml), and in the
presence or absence of PGE2 (10-6 M) for 4-7 days. Cultures were TRAP
stained, and TRAP positive MNC cells were counted using the digital
photography method. No TRAP positive MNCs were observed in cultures
without RANKL. Symbols are means ±SEM for n=3 wells. a Significant effect of
PGE2, p<.001; b p<.01.
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Hypothetical PGE2 Experiment
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Figure 14: Hypothetical PGE2 experiment showing phase shift of OC counts and
OC production. This hypothetical situation illustrates that there is no difference in
OC cycle or the long term effects on OC counts from PGE2, rather, just a shift in
the OC production phase. Note, OC counts at days 4, 5, and 6 would indicate
PGE2 inhibits OC formation, at day 7 there is no significant difference, while at
days 8, 9, and 10 PGE2 stimulates OC formation.
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